Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The National Cancer Institute and Department of Veterans Affairs Interagency Group to Accelerate Trials Enrollment (NAVIGATE): A federal collaboration to improve cancer care.

Schiller SJ, Shannon C, Brophy MT, Denicoff AM, Good MJ, Prindiville SA, Huang GD.

Semin Oncol. 2019 Aug - Oct;46(4-5):308-313. doi: 10.1053/j.seminoncol.2019.09.005. Epub 2019 Oct 22.

PMID:
31711680
2.

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.

Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW.

Clin Cancer Res. 2016 Apr 15;22(8):1907-13. doi: 10.1158/1078-0432.CCR-16-0104. Epub 2016 Feb 17.

3.

An Improved Breast Epithelial Sampling Method for Molecular Profiling and Biomarker Analysis in Women at Risk for Breast Cancer.

Danforth DN, Warner AC, Wangsa D, Ried T, Duelli D, Filie AC, Prindiville SA.

Breast Cancer (Auckl). 2015 Jun 8;9:31-40. doi: 10.4137/BCBCR.S23577. eCollection 2015.

4.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study.

Gierach GL, Li H, Loud JT, Greene MH, Chow CK, Lan L, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Olopade OI, Gail MH, Giger ML.

Breast Cancer Res. 2014;16(4):424. doi: 10.1186/PREACCEPT-1744229618121391. Epub 2014 Aug 23.

5.

Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials.

Abrams JS, Mooney MM, Zwiebel JA, Korn EL, Friedman SH, Finnigan SR, Schettino PR, Denicoff AM, Kruhm MG, Montello M, Misra RR, Ansher SS, DiPiazza KJ, Souhan EM, Wickerham DL, Giantonio BJ, O'Donnell RT, Sullivan DM, Soto NI, Fleming GF, Prindiville SA, Petryshyn RA, Hautala JA, Grad O, Zuckerman BL, Meyer RM, Yao JC, Baker LA, Buckner JC, Hortobagyi GN, Doroshow JH.

J Natl Cancer Inst. 2013 Jul 3;105(13):954-9. doi: 10.1093/jnci/djt137. Epub 2013 Jun 17.

6.

Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.

Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ, Christensen R, Prindiville SA, Calzone KA, Soballe PW, Hu Y, Chowdhury SA, Schwartz R, Schäffer AA, Ried T.

Am J Pathol. 2012 Nov;181(5):1807-22. doi: 10.1016/j.ajpath.2012.07.012. Epub 2012 Oct 8.

7.

Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.

Prindiville SA, Ried T.

Cancer Prev Res (Phila). 2010 Apr;3(4):416-9. doi: 10.1158/1940-6207.CAPR-10-0045. Epub 2010 Mar 23. Review.

8.

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.

Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH.

Breast Cancer Res Treat. 2010 Aug;123(1):245-55. doi: 10.1007/s10549-010-0749-7. Epub 2010 Feb 4.

9.

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.

Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM.

Clin Cancer Res. 2009 Sep 1;15(17):5323-37. doi: 10.1158/1078-0432.CCR-09-0737.

10.

Recruitment to a physical activity intervention study in women at increased risk of breast cancer.

Korde LA, Micheli A, Smith AW, Venzon D, Prindiville SA, Drinkard B, Sebring N, Smith MD, Zujewski JA, Eng-Wong J.

BMC Med Res Methodol. 2009 Apr 27;9:27. doi: 10.1186/1471-2288-9-27.

11.

Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?

Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1243-51. doi: 10.1158/1055-9965.EPI-08-0795. Epub 2009 Mar 31.

12.

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Górski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Am J Hum Genet. 2007 Dec;81(6):1186-200. Epub 2007 Oct 16.

13.

Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.

Jenkins J, Calzone KA, Dimond E, Liewehr DJ, Steinberg SM, Jourkiv O, Klein P, Soballe PW, Prindiville SA, Kirsch IR.

Genet Med. 2007 Aug;9(8):487-95.

PMID:
17700386
14.

Combined breast ductal lavage and ductal endoscopy for the evaluation of the high-risk breast: a feasibility study.

Danforth DN Jr, Abati A, Filie A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS.

J Surg Oncol. 2006 Dec 1;94(7):555-64.

PMID:
17048242
15.

The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors.

De Soto JA, Wang X, Tominaga Y, Wang RH, Cao L, Qiao W, Li C, Xu X, Skoumbourdis AP, Prindiville SA, Thomas CJ, Deng CX.

Int J Biol Sci. 2006;2(4):179-85. Epub 2006 Jun 10.

16.

Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.

Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1153-8.

17.

High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.

Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA Jr, Miller YE.

Lung Cancer. 2005 Aug;49(2):187-91. Epub 2005 Apr 14.

PMID:
16022912
18.

Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.

Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, Liewehr DJ, Steinberg SM, Soballe PW, Lipkowitz S, Klein P, Kirsch IR.

J Clin Oncol. 2005 May 20;23(15):3455-64.

PMID:
15908654
19.

High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.

Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA Jr, Miller YE.

Chest. 2004 May;125(5 Suppl):109S. No abstract available.

PMID:
15136448
20.

Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.

Prindiville SA, Byers T, Hirsch FR, Franklin WA, Miller YE, Vu KO, Wolf HJ, Barón AE, Shroyer KR, Zeng C, Kennedy TC, Bunn PA.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):987-93.

21.

Patient age and cancer treatment decisions. Patient and physician views.

Kutner JS, Vu KO, Prindiville SA, Byers TE.

Cancer Pract. 2000 May-Jun;8(3):114-9.

PMID:
11898135
22.

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.

Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, Bunn PA Jr, Kennedy TC.

J Natl Cancer Inst. 2001 Sep 19;93(18):1385-91.

PMID:
11562389
23.

Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome.

Nicolls MR, Terada LS, Tuder RM, Prindiville SA, Schwarz MI.

Am J Respir Crit Care Med. 1998 Oct;158(4):1302-5.

PMID:
9769296
24.

Aspirin and the risk of colorectal cancer in women.

Johnson KA, Prindiville SA.

N Engl J Med. 1996 Jan 11;334(2):119; author reply 121. No abstract available.

PMID:
8531946
25.

Anaphylactoid reaction with suramin.

Thibault A, Figg WD, Cooper MR, Prindiville SA, Sartor AO, Headlee DJ, Myers CE.

Pharmacotherapy. 1993 Nov-Dec;13(6):656-7. Erratum in: Pharmacotherapy 1994 Jan-Feb;14(1):following 125.

PMID:
8302692

Supplemental Content

Loading ...
Support Center